{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:24Z","timestamp":1790516544839,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Societ\u00e0 Italiana dell\u2019Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40618-021-01676-4","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T07:03:12Z","timestamp":1631689392000},"page":"517-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-2299","authenticated-orcid":false,"given":"Antonino","family":"Catalano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunziata","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"3","key":"1676_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0959-437x(03)00048-0","volume":"13","author":"I Dalkilic","year":"2003","unstructured":"Dalkilic I, Kunkel LM (2003) Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 13(3):231\u2013238. https:\/\/doi.org\/10.1016\/s0959-437x(03)00048-0","journal-title":"Curr Opin Genet Dev"},{"key":"1676_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003725.pub4","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (2016) Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003725.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1676_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347\u2013361. https:\/\/doi.org\/10.1016\/S1474-4422(18)30025-5","journal-title":"Lancet Neurol"},{"issue":"12","key":"1676_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.nmd.2012.06.354","volume":"22","author":"AL Mayo","year":"2012","unstructured":"Mayo AL, Craven BC, McAdam LC, Biggar WD (2012) Bone health in boys with Duchenne muscular dystrophy on long-term daily deflazacort therapy. Neuromuscul Disord 22(12):1040\u20131045. https:\/\/doi.org\/10.1016\/j.nmd.2012.06.354","journal-title":"Neuromuscul Disord"},{"key":"1676_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/928385","volume":"2015","author":"JL Buckner","year":"2015","unstructured":"Buckner JL, Bowden SA, Mahan JD (2015) Optimizing bone health in duchenne muscular dystrophy. Int J Endocrinol 2015:928385. https:\/\/doi.org\/10.1155\/2015\/928385","journal-title":"Int J Endocrinol"},{"issue":"6","key":"1676_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jamaneurol.2019.0242","volume":"76","author":"S Joseph","year":"2019","unstructured":"Joseph S, Wang C, Bushby K et al (2019) Fractures and linear growth in a nationwide cohort of boys with Duchenne muscular dystrophy with and without glucocorticoid treatment: results from the UK northstar database. JAMA Neurol 76(6):701\u2013709. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0242","journal-title":"JAMA Neurol"},{"issue":"2","key":"1676_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","volume":"28","author":"J Ma","year":"2017","unstructured":"Ma J, McMillan HJ, Karag\u00fczel G et al (2017) The time to and determinants of first fractures in boys with Duchenne muscular dystrophy. Osteoporos Int 28(2):597\u2013608. https:\/\/doi.org\/10.1007\/s00198-016-3774-5","journal-title":"Osteoporos Int"},{"issue":"8","key":"1676_CR8","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M et al (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891\u20131903. https:\/\/doi.org\/10.1002\/jbmr.410","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1676_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11914-018-0468-2","volume":"16","author":"A Boulanger Piette","year":"2018","unstructured":"Boulanger Piette A, Hamoudi D, Marcadet L et al (2018) Targeting the muscle-bone unit: filling two needs with one deed in the treatment of Duchenne muscular dystrophy. Curr Osteoporos Rep 16(5):541\u2013553. https:\/\/doi.org\/10.1007\/s11914-018-0468-2","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"1676_CR10","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00198-019-05077-5","volume":"30","author":"S Akhtar Ali","year":"2019","unstructured":"Akhtar Ali S, Kang H, Olney R et al (2019) Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy. Osteoporos Int 30(11):2283\u20132288. https:\/\/doi.org\/10.1007\/s00198-019-05077-5","journal-title":"Osteoporos Int"},{"issue":"9","key":"1676_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","volume":"14","author":"ML Bianchi","year":"2003","unstructured":"Bianchi ML, Mazzanti A, Galbiati E et al (2003) Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14(9):761\u2013767. https:\/\/doi.org\/10.1007\/s00198-003-1443-y","journal-title":"Osteoporos Int"},{"issue":"2","key":"1676_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00198-010-1275-5","volume":"22","author":"ML Bianchi","year":"2011","unstructured":"Bianchi ML, Morandi L, Andreucci E, Vai S, Frasunkiewicz J, Cottafava R (2011) Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment. Osteoporos Int 22(2):529\u2013539. https:\/\/doi.org\/10.1007\/s00198-010-1275-5","journal-title":"Osteoporos Int"},{"issue":"11\u201312","key":"1676_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","volume":"17","author":"AC S\u00f6derpalm","year":"2007","unstructured":"S\u00f6derpalm AC, Magnusson P, Ahlander AC et al (2007) Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 17(11\u201312):919\u2013928. https:\/\/doi.org\/10.1016\/j.nmd.2007.05.008","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1676_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00198-013-2442-2","volume":"25","author":"S Pouwels","year":"2014","unstructured":"Pouwels S, de Boer A, Leufkens HG et al (2014) Risk of fracture in patients with muscular dystrophies. Osteoporos Int 25(2):509\u2013518. https:\/\/doi.org\/10.1007\/s00198-013-2442-2","journal-title":"Osteoporos Int"},{"issue":"12","key":"1676_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","volume":"23","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Bianchi ML, Eisman JA et al (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23(12):2735\u20132748. https:\/\/doi.org\/10.1007\/s00198-012-2030-x","journal-title":"Osteoporos Int"},{"issue":"1","key":"1676_CR16","first-page":"71","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20(1):71\u201374","journal-title":"J Pediatr Orthop"},{"key":"1676_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010899.pub2","author":"JM Bell","year":"2017","unstructured":"Bell JM, Shields MD, Watters J et al (2017) Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010899.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1676_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","volume":"182","author":"BL Wong","year":"2017","unstructured":"Wong BL, Rybalsky I, Shellenbarger KC et al (2017) Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment. J Pediatr 182:296-303.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.11.078","journal-title":"J Pediatr"},{"issue":"1","key":"1676_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11914-014-0197-0","volume":"12","author":"N Gua\u00f1abens","year":"2014","unstructured":"Gua\u00f1abens N, Gifre L, Peris P (2014) The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis. Curr Osteoporos Rep 12(1):90\u201397. https:\/\/doi.org\/10.1007\/s11914-014-0197-0","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"1676_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","volume":"87","author":"MJ Moester","year":"2010","unstructured":"Moester MJ, Papapoulos SE, L\u00f6wik CW, van Bezooijen RL (2010) Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 87(2):99\u2013107. https:\/\/doi.org\/10.1007\/s00223-010-9372-1","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1676_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00223-016-0126-6","volume":"98","author":"NM Appelman-Dijkstra","year":"2016","unstructured":"Appelman-Dijkstra NM, Papapoulos SE (2016) Sclerostin inhibition in the management of osteoporosis. Calcif Tissue Int 98(4):370\u2013380. https:\/\/doi.org\/10.1007\/s00223-016-0126-6","journal-title":"Calcif Tissue Int"},{"issue":"23","key":"1676_CR22","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC et al (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267\u20136276. https:\/\/doi.org\/10.1093\/emboj\/cdg599","journal-title":"EMBO J"},{"issue":"6","key":"1676_CR23","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X, Ominsky MS, Niu QT et al (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23(6):860\u2013869. https:\/\/doi.org\/10.1359\/jbmr.080216","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1676_CR24","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1210\/jc.2010-0067","volume":"95","author":"A Gaudio","year":"2010","unstructured":"Gaudio A, Pennisi P, Bratengeier C et al (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95(5):2248\u20132253. https:\/\/doi.org\/10.1210\/jc.2010-0067","journal-title":"J Clin Endocrinol Metab"},{"issue":"10119","key":"1676_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT et al (2018) Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 391(10119):451\u2013461. https:\/\/doi.org\/10.1016\/S0140-6736(17)32160-8","journal-title":"Lancet"},{"issue":"10","key":"1676_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-017-0492-4","volume":"34","author":"A Catalano","year":"2017","unstructured":"Catalano A, Martino G, Morabito N, Scarcella C, Gaudio A, Basile G, Lasco A (2017) Pain in osteoporosis: from pathophysiology to therapeutic approach. Drugs Aging 34(10):755\u2013765. https:\/\/doi.org\/10.1007\/s40266-017-0492-4 (PMID: 28980156)","journal-title":"Drugs Aging"},{"issue":"2","key":"1676_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocd.2014.01.005","volume":"17","author":"ML Bianchi","year":"2014","unstructured":"Bianchi ML, Leonard MB, Bechtold S et al (2014) Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD pediatric official positions. J Clin Densitom 17(2):281\u2013294. https:\/\/doi.org\/10.1016\/j.jocd.2014.01.005","journal-title":"J Clin Densitom"},{"issue":"12","key":"1676_CR28","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s00198-016-3761-x","volume":"27","author":"A Catalano","year":"2016","unstructured":"Catalano A, Vita GL, Russo M et al (2016) Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report. Osteoporos Int 27(12):3655\u20133659. https:\/\/doi.org\/10.1007\/s00198-016-3761-x","journal-title":"Osteoporos Int"},{"issue":"3","key":"1676_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1210\/jc.2009-2057","volume":"95","author":"BS Zemel","year":"2010","unstructured":"Zemel BS, Leonard MB, Kelly A et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265\u20131273. https:\/\/doi.org\/10.1210\/jc.2009-2057","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1676_CR30","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00198-020-05549-z","volume":"31","author":"N Nasomyont","year":"2020","unstructured":"Nasomyont N, Keefe C, Tian C et al (2020) Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Osteoporos Int 31(12):2449\u20132459. https:\/\/doi.org\/10.1007\/s00198-020-05549-z","journal-title":"Osteoporos Int"},{"issue":"12","key":"1676_CR31","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.4158\/EP-2020-0073","volume":"26","author":"WB Zheng","year":"2020","unstructured":"Zheng WB, Dai Y, Hu J et al (2020) Effects of bisphosphonates on osteoporosis induced by Duchenne muscular dystrophy: a prospective study. Endocr Pract 26(12):1477\u20131485. https:\/\/doi.org\/10.4158\/EP-2020-0073","journal-title":"Endocr Pract"},{"key":"1676_CR32","doi-asserted-by":"publisher","first-page":"64s","DOI":"10.1183\/09031936.03.00004609","volume":"46","author":"AA Ionescu","year":"2003","unstructured":"Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:64s\u201375s. https:\/\/doi.org\/10.1183\/09031936.03.00004609","journal-title":"Eur Respir J Suppl"},{"issue":"10","key":"1676_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18(10):1319\u20131328. https:\/\/doi.org\/10.1007\/s00198-007-0394-0","journal-title":"Osteoporos Int"},{"issue":"3","key":"1676_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00198-017-4337-0","volume":"29","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Shiraki M, Saito M, Okazaki R, Inoue D (2018) Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Osteoporos Int 29(3):625\u2013633. https:\/\/doi.org\/10.1007\/s00198-017-4337-0","journal-title":"Osteoporos Int"},{"issue":"3","key":"1676_CR35","first-page":"191","volume":"10","author":"A Catalano","year":"2013","unstructured":"Catalano A, Morabito N, Basile G et al (2013) Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab 10(3):191\u2013194","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"3","key":"1676_CR36","first-page":"352","volume":"18","author":"A Lasco","year":"2014","unstructured":"Lasco A, Catalano A, Pilato A, Basile G, Mallamace A, Atteritano M (2014) Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily. Eur Rev Med Pharmacol Sci 18(3):352\u2013358","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1676_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-011-1584-3","volume":"23","author":"M Ghazi","year":"2012","unstructured":"Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23(2):581\u2013587. https:\/\/doi.org\/10.1007\/s00198-011-1584-3","journal-title":"Osteoporos Int"},{"issue":"4","key":"1676_CR38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1210\/jc.2014-4177","volume":"100","author":"VV Zhukouskaya","year":"2015","unstructured":"Zhukouskaya VV, Eller-Vainicher C, Gaudio A et al (2015) In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. J Clin Endocrinol Metab 100(4):1417\u20131425. https:\/\/doi.org\/10.1210\/jc.2014-4177","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1676_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd","year":"2005","unstructured":"Glass DA 2nd, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8(5):751\u2013764. https:\/\/doi.org\/10.1016\/j.devcel.2005.02.017","journal-title":"Dev Cell"},{"issue":"5","key":"1676_CR40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2012-4039","volume":"98","author":"A Catalano","year":"2013","unstructured":"Catalano A, Morabito N, Basile G, Brancatelli S, Cucinotta D, Lasco A (2013) Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 98(5):1911\u20131915. https:\/\/doi.org\/10.1210\/jc.2012-4039","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1676_CR41","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3390\/ijms20122896","volume":"20","author":"T Ueland","year":"2019","unstructured":"Ueland T, Stilgren L, Bollerslev J (2019) Bone matrix levels of Dickkopf and sclerostin are positively correlated with bone mass and strength in postmenopausal osteoporosis. Int J Mol Sci 20(12):2896. https:\/\/doi.org\/10.3390\/ijms20122896","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1676_CR42","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/hmg\/ddz012","volume":"28","author":"X Gao","year":"2019","unstructured":"Gao X, Tang Y, Amra S et al (2019) Systemic investigation of bone and muscle abnormalities in dystrophin\/utrophin double knockout mice during postnatal development and the mechanisms. Hum Mol Genet 28(10):1738\u20131751. https:\/\/doi.org\/10.1093\/hmg\/ddz012","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1676_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40618-014-0236-9","volume":"38","author":"E Cairoli","year":"2015","unstructured":"Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I (2015) Perspectives on osteoporosis therapies. J Endocrinol Invest 38(3):303\u2013311. https:\/\/doi.org\/10.1007\/s40618-014-0236-9","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1676_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93(2):121\u2013132. https:\/\/doi.org\/10.1007\/s00223-013-9749-z","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1676_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4081\/reumatismo.2013.219","volume":"65","author":"S Tamanini","year":"2013","unstructured":"Tamanini S, Idolazzi L, Gatti D, Viapiana O, Fassio A, Rossini M (2013) Insight into the WNT system and its drug related response. Reumatismo 65(5):219\u2013230. https:\/\/doi.org\/10.4081\/reumatismo.2013.219","journal-title":"Reumatismo"},{"key":"1676_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2018.07.010","volume":"116","author":"A Catalano","year":"2018","unstructured":"Catalano A, Loddo S, Bellone F, Pecora C, Lasco A, Morabito N (2018) Pulsed electromagnetic fields modulate bone metabolism via RANKL\/OPG and Wnt\/\u03b2-catenin pathways in women with postmenopausal osteoporosis: a pilot study. Bone 116:42\u201346. https:\/\/doi.org\/10.1016\/j.bone.2018.07.010","journal-title":"Bone"},{"issue":"5","key":"1676_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00774-015-0689-8","volume":"34","author":"N Morabito","year":"2016","unstructured":"Morabito N, Catalano A, Gaudio A et al (2016) Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis. J Bone Miner Metab 34(5):540\u2013546. https:\/\/doi.org\/10.1007\/s00774-015-0689-8","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"1676_CR48","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1210\/jc.2011-2757","volume":"97","author":"ZE Davidson","year":"2012","unstructured":"Davidson ZE, Walker KZ, Truby H (2012) Clinical review: do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 97(3):738\u2013744. https:\/\/doi.org\/10.1210\/jc.2011-2757","journal-title":"J Clin Endocrinol Metab"},{"key":"1676_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X19835661","author":"Q Bian","year":"2019","unstructured":"Bian Q, McAdam L, Grynpas M, Mitchell J, Harrington J (2019) Increased rates of vitamin D insufficiency in boys with Duchenne muscular dystrophy despite higher vitamin D3 supplementation. Glob Pediatr Health. https:\/\/doi.org\/10.1177\/2333794X19835661","journal-title":"Glob Pediatr Health"},{"issue":"3","key":"1676_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12020-016-1146-8","volume":"54","author":"G Mazziotti","year":"2016","unstructured":"Mazziotti G, Formenti AM, Adler RA et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH\/IGF-I and PTH\/VITAMIN D axes, treatment options and guidelines. Endocrine 54(3):603\u2013611. https:\/\/doi.org\/10.1007\/s12020-016-1146-8","journal-title":"Endocrine"},{"issue":"3","key":"1676_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00223-014-9926-8","volume":"96","author":"MN Meriggioli","year":"2015","unstructured":"Meriggioli MN, Roubenoff R (2015) Prospect for pharmacological therapies to treat skeletal muscle dysfunction. Calcif Tissue Int 96(3):234\u2013242. https:\/\/doi.org\/10.1007\/s00223-014-9926-8","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"1676_CR52","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/jcp.25388","volume":"231","author":"K van der Meijden","year":"2016","unstructured":"van der Meijden K, Bravenboer N, Dirks NF et al (2016) Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 myoblast proliferation, differentiation, and myotube hypertrophy. J Cell Physiol 231(11):2517\u20132528. https:\/\/doi.org\/10.1002\/jcp.25388","journal-title":"J Cell Physiol"},{"issue":"4","key":"1676_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/archinternmed.2011.715","volume":"172","author":"A Lasco","year":"2012","unstructured":"Lasco A, Catalano A, Benvenga S (2012) Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med 172(4):366\u2013367. https:\/\/doi.org\/10.1001\/archinternmed.2011.715","journal-title":"Arch Intern Med"},{"issue":"2","key":"1676_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/SCS.0000000000002389","volume":"27","author":"G Oteri","year":"2016","unstructured":"Oteri G, Cicci\u00f9 M, Peditto M et al (2016) Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery. J Craniofac Surg 27(2):469\u2013476. https:\/\/doi.org\/10.1097\/SCS.0000000000002389","journal-title":"J Craniofac Surg"},{"issue":"3","key":"1676_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/metabo10030115","volume":"10","author":"G Gembillo","year":"2020","unstructured":"Gembillo G, Cernaro V, Siligato R, Curreri F, Catalano A, Santoro D (2020) Protective role of Vitamin D in renal tubulopathies. Metabolites 10(3):115. https:\/\/doi.org\/10.3390\/metabo10030115","journal-title":"Metabolites"},{"issue":"4","key":"1676_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00223-012-9577-6","volume":"90","author":"A Catalano","year":"2012","unstructured":"Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A (2012) Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis. Calcif Tissue Int 90(4):279\u2013285. https:\/\/doi.org\/10.1007\/s00223-012-9577-6","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1676_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nmd.2016.01.003","volume":"26","author":"S Messina","year":"2016","unstructured":"Messina S, Vita GL, Sframeli M et al (2016) Health-related quality of life and functional changes in DMD: a 12-month longitudinal cohort study. Neuromuscul Disord 26(3):189\u2013196. https:\/\/doi.org\/10.1016\/j.nmd.2016.01.003","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"1676_CR58","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10072-018-3555-3","volume":"39","author":"S Messina","year":"2018","unstructured":"Messina S, Vita GL (2018) Clinical management of Duchenne muscular dystrophy: the state of the art. Neurol Sci 39(11):1837\u20131845. https:\/\/doi.org\/10.1007\/s10072-018-3555-3","journal-title":"Neurol Sci"},{"issue":"10","key":"1676_CR59","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/GME.0000000000001123","volume":"25","author":"A Catalano","year":"2018","unstructured":"Catalano A, Martino G, Bellone F et al (2018) Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis. Menopause 25(10):1110\u20131115. https:\/\/doi.org\/10.1097\/GME.0000000000001123","journal-title":"Menopause"},{"issue":"1","key":"1676_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052512","volume":"8","author":"ES Mazzone","year":"2013","unstructured":"Mazzone ES, Pane M, Sormani MP et al (2013) 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. PLoS ONE 8(1):e52512. https:\/\/doi.org\/10.1371\/journal.pone.0052512","journal-title":"PLoS ONE"},{"issue":"4","key":"1676_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10072-019-03764-z","volume":"40","author":"G Vita","year":"2019","unstructured":"Vita G, Vita GL, Musumeci O, Rodolico C, Messina S (2019) Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle. Neurol Sci 40(4):671\u2013681. https:\/\/doi.org\/10.1007\/s10072-019-03764-z","journal-title":"Neurol Sci"},{"issue":"12","key":"1676_CR62","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726\u20131733. https:\/\/doi.org\/10.1007\/s00198-006-0172-4","journal-title":"Osteoporos Int"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01676-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T10:31:45Z","timestamp":1645007505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01676-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01676-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Antonino Catalano, Gian Luca Vita, Federica Bellone, Maria Sframeli, Maria Grazia Distefano, Matteo La Rosa, Agostino Gaudio, Giuseppe Vita, Nunziata Morabito and Sonia Messina have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of Scientific Ethic Committee of the AOU Policlinico \u201cG. Martino\u201d, Messina, Italy (Prot. 20-12) and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical\u00a0approval"}},{"value":"An informed consent was obtained from all participants included in the study or from their parents as appropriate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}